Edgewise Therapeutics (EWTX) News Today $14.38 -2.17 (-13.09%) Closing price 03:59 PM EasternExtended Trading$14.11 -0.27 (-1.84%) As of 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Baker BROS. Advisors LP Buys 315,881 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Baker BROS. Advisors LP boosted its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 5.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,155,940 shares of the company's stock after purchaMay 6 at 7:39 AM | marketbeat.comIs Edgewise Therapeutics, Inc. (EWTX) the Best Small Cap Stock to Buy with the Biggest Upside Potential?May 5 at 8:07 AM | insidermonkey.comAlly Bridge Group NY LLC Trims Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Ally Bridge Group NY LLC trimmed its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 55.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 83,176 shares of the company's stock after sellingMay 4 at 7:45 AM | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Acuta Capital Partners LLCAcuta Capital Partners LLC increased its stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 39.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 87,658 sharesMay 4 at 7:14 AM | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC trimmed its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 50.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor ownedMay 4 at 5:06 AM | marketbeat.comInvesco Ltd. Sells 21,341 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Invesco Ltd. lessened its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 32.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 43,435 shares of the company's stock after selling 21,341 shares during theMay 4 at 3:14 AM | marketbeat.comNovo Holdings A S Decreases Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Novo Holdings A S reduced its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 9.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,000,000 shares of the company's stock afteMay 3 at 8:09 AM | marketbeat.comEdgewise Therapeutics (EWTX) to Release Quarterly Earnings on ThursdayEdgewise Therapeutics (NASDAQ:EWTX) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-cricut-stock/)May 3 at 6:20 AM | marketbeat.comMarshall Wace LLP Sells 547,672 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Marshall Wace LLP reduced its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 94.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,893 shares of the company's stock aMay 3 at 3:47 AM | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Coverage Initiated by Analysts at GuggenheimMay 3 at 3:11 AM | americanbankingnews.comWhy Edgewise Therapeutics Stock Popped This WeekMay 2, 2025 | fool.comGuggenheim Initiates Coverage on Edgewise Therapeutics (NASDAQ:EWTX)Guggenheim assumed coverage on Edgewise Therapeutics in a research report on Wednesday. They set a "buy" rating and a $41.00 price objective for the company.May 2, 2025 | marketbeat.comVoya Investment Management LLC Reduces Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Voya Investment Management LLC lessened its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 7.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 284,148 shares of the cMay 2, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. boosted its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 1,015.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 240,000 shares of the companyMay 1, 2025 | marketbeat.com780,639 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Purchased by First Light Asset Management LLCFirst Light Asset Management LLC acquired a new stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 780,639 shares of the company's stock, valued atApril 30, 2025 | marketbeat.comForesite Capital Management VI LLC Purchases New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Foresite Capital Management VI LLC purchased a new stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 585,000 shares of the company's stock,April 30, 2025 | marketbeat.comIs Edgewise Therapeutics Inc. (NASDAQ:EWTX) the Most Promising Small-Cap Stock According to Analysts?April 25, 2025 | msn.comHarvest Investment Services LLC Invests $2.12 Million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Harvest Investment Services LLC bought a new stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 79,381 shares of the company's stock, vaApril 24, 2025 | marketbeat.comWedbush Reaffirms "Outperform" Rating for Edgewise Therapeutics (NASDAQ:EWTX)Wedbush reaffirmed an "outperform" rating and set a $43.00 price target on shares of Edgewise Therapeutics in a research report on Monday.April 23, 2025 | marketbeat.com33,079 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Acquired by Russell Investments Group Ltd.Russell Investments Group Ltd. acquired a new stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 33,079 shares of the company's stock, valued at approximately $883,000. Several othApril 23, 2025 | marketbeat.comJPMorgan Chase & Co. Has $3.32 Million Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)JPMorgan Chase & Co. lowered its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 21.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 124,435 shares of theApril 23, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Jump Financial LLCJump Financial LLC trimmed its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 58.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 55,178 shares of the company's stock after selling 76,628 shares dApril 22, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eight analysts that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and six have issued a buy recApril 22, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by EAM Investors LLCEAM Investors LLC trimmed its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 27.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 91,333 shares of the company's stock after selling 33,April 19, 2025 | marketbeat.comWalleye Capital LLC Sells 43,589 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Walleye Capital LLC reduced its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 18.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 198,662 shares of the company's stock after selling 43,589April 19, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 9.4% - Here's What HappenedEdgewise Therapeutics (NASDAQ:EWTX) Shares Up 9.4% - Time to Buy?April 17, 2025 | marketbeat.comNew Leaf Venture Partners L.L.C. Sells 523,500 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)New Leaf Venture Partners L.L.C. cut its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 33.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,030,161 shares of the coApril 16, 2025 | marketbeat.com47,755 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Norges BankNorges Bank purchased a new stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 47,755 shares of the company's stock, valued at approxiApril 14, 2025 | marketbeat.comTrexquant Investment LP Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Trexquant Investment LP bought a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 74,781 shares of the company's stock, vApril 11, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Hits New 12-Month Low - What's Next?Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 1-Year Low - Here's What HappenedApril 10, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Stake Reduced by Vanguard Group Inc.Vanguard Group Inc. trimmed its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 1.1% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 4,466,849 shares of the company's stock after selling 49,214 shares during the quarter. Vanguard GApril 10, 2025 | marketbeat.comBiotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & MoreApril 10, 2025 | msn.comEdgewise Therapeutics, Inc. (EWTX): Among Stocks Insiders Bought in April After Trump’s Tariff RolloutApril 8, 2025 | insidermonkey.comEdgewise Therapeutics, Inc. (EWTX): Among Stocks Insiders Bought in April After Trump’s Tariff RolloutApril 8, 2025 | msn.comThese 5 Insiders Are Buying During Market ChaosApril 8, 2025 | 247wallst.com93,061 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Acquired by Schroder Investment Management GroupSchroder Investment Management Group bought a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 93,061 shares of the company's stock, valApril 8, 2025 | marketbeat.comLeerink Partnrs Has Strong Estimate for EWTX Q1 EarningsEdgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) - Research analysts at Leerink Partnrs lifted their Q1 2025 earnings estimates for Edgewise Therapeutics in a report released on Wednesday, April 2nd. Leerink Partnrs analyst J. Schwartz now forecasts that the company will post earnings perApril 8, 2025 | marketbeat.comQ1 EPS Estimates for Edgewise Therapeutics Cut by WedbushEdgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) - Equities research analysts at Wedbush reduced their Q1 2025 EPS estimates for Edgewise Therapeutics in a research note issued to investors on Wednesday, April 2nd. Wedbush analyst L. Chico now anticipates that the company will post earningApril 8, 2025 | marketbeat.comInsider Buying: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Director Purchases 496,771 Shares of StockEdgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) Director Orbimed Advisors Llc bought 496,771 shares of the company's stock in a transaction dated Thursday, April 3rd. The stock was acquired at an average price of $20.13 per share, for a total transaction of $10,000,000.23. Following the acquisition, the director now directly owns 14,809,075 shares in the company, valued at $298,106,679.75. This trade represents a 3.47 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.April 6, 2025 | marketbeat.comCinctive Capital Management LP Has $376,000 Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Cinctive Capital Management LP decreased its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 81.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,093 shares of the company's stock afteApril 6, 2025 | marketbeat.comEdgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your MoneyApril 5, 2025 | msn.comEdgewise Therapeutics (NASDAQ:EWTX) Sees Unusually-High Trading Volume - Time to Buy?Edgewise Therapeutics (NASDAQ:EWTX) Sees Strong Trading Volume - Still a Buy?April 5, 2025 | marketbeat.comRoyal Bank of Canada Lowers Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $52.00Royal Bank of Canada dropped their price target on shares of Edgewise Therapeutics from $56.00 to $52.00 and set an "outperform" rating on the stock in a research report on Thursday.April 5, 2025 | marketbeat.comOrbimed Advisors Llc Purchases 496,771 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) StockApril 5, 2025 | insidertrades.comPictet Asset Management Holding SA Takes $8.04 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Pictet Asset Management Holding SA purchased a new position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 301,241 shares of the company's stocApril 5, 2025 | marketbeat.comPiper Sandler Reiterates Overweight Rating for Edgewise Therapeutics (NASDAQ:EWTX)Piper Sandler restated an "overweight" rating and issued a $51.00 price objective on shares of Edgewise Therapeutics in a research note on Wednesday.April 4, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Lowered to Sector Perform Rating by ScotiabankScotiabank cut shares of Edgewise Therapeutics from a "sector outperform" rating to a "sector perform" rating and set a $14.00 target price on the stock. in a research note on Wednesday.April 4, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Rating Lowered to "Sector Perform" at ScotiabankScotiabank cut shares of Edgewise Therapeutics from a "sector outperform" rating to a "sector perform" rating and set a $14.00 target price for the company. in a research note on Wednesday.April 4, 2025 | marketbeat.comInvestors Buy High Volume of Put Options on Edgewise Therapeutics (NASDAQ:EWTX)Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Stock traders bought 13,313 put options on the stock. This is an increase of approximately 873% compared to the average daily volume of 1,368 put options.April 4, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Hits New 12-Month Low - Should You Sell?Edgewise Therapeutics (NASDAQ:EWTX) Hits New 1-Year Low - Should You Sell?April 4, 2025 | marketbeat.com Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address EWTX Media Mentions By Week EWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EWTX News Sentiment▼1.240.69▲Average Medical News Sentiment EWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EWTX Articles This Week▼185▲EWTX Articles Average Week Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Legend Biotech News Today Sarepta Therapeutics News Today Telix Pharmaceuticals Limited American Depositary Shares News Today ADMA Biologics News Today Blueprint Medicines News Today Verona Pharma News Today Nuvalent News Today Axsome Therapeutics News Today Grifols News Today Cytokinetics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EWTX) was last updated on 5/6/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump's tariffs on China have caused a ripple effect across global markets. But in crypto? They've lit a fu...Crypto 101 Media | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EWTX Stock Free EWTX Stock Alerts